Bank of America’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Bank of America’s Portfolio TLSIW Stock Details TLSIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,009	Closed	-$1.68K	–	6818
2025 Q4	$1.68K	Buy	+1,009	New	+$1.28K	﹤0.01%	6425
2025 Q2	–	Sell	-176	Closed	-$204	–	8664
2025 Q1	$204	Buy	+176	New	+$227	﹤0.01%	7687

Other funds holding TLSIW

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

FBCM

Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Bank of America's TLSIW Position: Q1 2026 in Review

Bank of America sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2026, closing a stake of 1,009 shares — an estimated $1.68K sold.

Bank of America first reported a position in TLSIW in Q1 2025 and held it in 2 quarters. The position peaked at $1.68K in Q4 2025. 7 funds tracked by Wall St. Rank hold TLSIW as of Q1 2026.

Bank of America reported no remaining TriSalus Life Sciences Warrant position as of Q1 2026 after selling out during the quarter.
Bank of America sold 1,009 TriSalus Life Sciences Warrant shares in Q1 2026, an estimated $1.68K.
Bank of America first reported a position in TriSalus Life Sciences Warrant in Q1 2025 and held it in 2 quarters.
Bank of America's TriSalus Life Sciences Warrant position peaked at $1.68K in Q4 2025.
7 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.